Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
22.69
+0.99 (4.56%)
At close: Mar 10, 2026
SHE:002393 Revenue
In the year 2025, Tianjin Lisheng Pharmaceutical had annual revenue of 1.39B CNY with 4.23% growth. Tianjin Lisheng Pharmaceutical had revenue of 385.38M in the quarter ending December 31, 2025, with 23.37% growth.
Revenue
1.39B
Revenue Growth
+4.23%
P/S Ratio
4.17
Revenue / Employee
868.24K
Employees
1,604
Market Cap
5.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.39B | 56.51M | 4.23% |
| Dec 31, 2024 | 1.34B | 183.12M | 15.88% |
| Dec 31, 2023 | 1.15B | 6.44M | 0.56% |
| Jan 1, 2023 | 1.15B | 54.65M | 5.00% |
| Jan 1, 2022 | 1.09B | -48.90M | -4.29% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teyi Pharmaceutical Group Co.,Ltd | 924.04M |
| Shandong Sinobioway Biomedicine | 257.74M |
| Zhejiang Sunflower Great Health | 302.92M |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.52B |
| Zhongzhu Healthcare Holding Co.,Ltd | 570.62M |
| Jiangsu Jibeier Pharmaceutical | 964.93M |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Chongqing Pharscin Pharmaceutical | 786.51M |